Prospective comprehensive molecular characterization of lung adenocarcinomas for efficient patient matching to approved and emerging therapies

Tumor genetic testing is standard of care for patients with advanced lung adenocarcinoma but the fraction of patients who derive clinical benefit remains undefined. Here, we report the experience of 860 patients with metastatic lung adenocarcinoma analyzed prospectively for mutations in >300 canc...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Cancer Discov
Glavni autori: Jordan, Emmet J., Kim, Hyunjae R., Arcila, Maria E., Barron, David, Chakravarty, Debyani, Gao, JianJiong, Chang, Matthew T., Ni, Andy, Kundra, Ritika, Jonsson, Philip, Jayakumaran, Gowtham, Gao, Sizhi Paul, Johnsen, Hannah C., Hanrahan, Aphrothiti J., Zehir, Ahmet, Rekhtman, Natasha, Ginsberg, Michelle S., Li, Bob T., Yu, Helena A., Paik, Paul K., Drilon, Alexander, Hellmann, Matthew D., Reales, Dalicia N., Benayed, Ryma, Rusch, Valerie W., Kris, Mark G., Chaft, Jamie E., Baselga, Jose, Taylor, Barry S., Schultz, Nikolaus, Rudin, Charles M., Hyman, David M., Berger, Michael F., Solit, David B., Ladanyi, Marc, Riely, Gregory J.
Format: Artigo
Jezik:Inglês
Izdano: 2017
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5482929/
https://ncbi.nlm.nih.gov/pubmed/28336552
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2159-8290.CD-16-1337
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items